Accuracy& Orbital Volume Using Patient Specific Titanium Implant Vs Zirconia for Orbital Floor Reconstruction
Launched by CAIRO UNIVERSITY · Apr 11, 2024
Trial Information
Current as of October 15, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of implants used for repairing the orbital floor, which is the area under the eye that can be damaged in injuries known as blow-out fractures. The study aims to compare a custom-made zirconia implant with a custom-made titanium implant to see which one provides better accuracy during surgery, fits better, maintains the correct volume of the eye socket, and causes fewer issues with the surrounding tissues, all while being more cost-effective.
To participate in this trial, individuals need to be between 18 and 60 years old and have a blow-out fracture, either on its own or alongside other fractures. They should be healthy enough for surgery and willing to follow through with the procedure and any necessary aftercare. However, people who have had previous eye socket surgeries, have certain health issues, or cannot cooperate during the study will not be eligible. Participants can expect to be closely monitored during and after the surgery to assess how well each type of implant works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with blow out fracture isolated and / or combined with other fracture.
- • Age group: from 18 to 60 years old
- • No sex predilection
- • Patients with no contraindications to surgical intervention.
- • Patients willing for the surgical procedure and follow-up, with an informed consent.
- Exclusion Criteria :
- • Medically compromised patients.
- • Patients with history of previous orbital reconstruction surgery.
- • Uncooperative patients.
- • Patients with systemic contraindication to general anesthesia.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Egypt
Patients applied
Trial Officials
OLA A. ELMORSY, PHD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported